PRECISION BIOSCIENCES INC Basic Shares Outstanding (Weighted Average)
PRECISION BIOSCIENCES INC (DTIL) reported Basic Shares Outstanding (Weighted Average) of 25.86 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- PRECISION BIOSCIENCES INC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 25.86M shares, a 134.07% increase year-over-year.
- PRECISION BIOSCIENCES INC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 24.63M shares, a 165.11% increase year-over-year.
- PRECISION BIOSCIENCES INC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 19.12M shares, a 138.76% increase year-over-year.
- PRECISION BIOSCIENCES INC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 11.82M shares, a 62.18% increase year-over-year.
- PRECISION BIOSCIENCES INC weighted average number of shares outstanding, basic for fiscal 2025 was 12.83M shares, a 87.71% increase from fiscal 2024.
- PRECISION BIOSCIENCES INC weighted average number of shares outstanding, basic for fiscal 2024 was 6.83M shares, a 77.88% increase from fiscal 2023.
- PRECISION BIOSCIENCES INC weighted average number of shares outstanding, basic for fiscal 2023 was 3.84M shares, a 31.11% increase from fiscal 2022.
- PRECISION BIOSCIENCES INC weighted average number of shares outstanding, basic for fiscal 2022 was 2.93M shares, a 95.01% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 25.86M shares 10-Q · filed 2026-08-06 | 25.25M shares 10-Q · filed 2026-08-06 | 23.20M shares derived: average of 3 quarters · filed 2026-08-06 | 20.36M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 24.63M shares 10-Q · filed 2026-05-05 | 21.88M shares derived: average of 2 quarters · filed 2026-05-05 | 18.52M shares derived: average of 3 quarters · filed 2026-05-05 | 16.65M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 19.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 15.47M shares derived: average of 2 quarters · filed 2026-03-12 | 13.99M shares derived: average of 3 quarters · filed 2026-08-06 | 12.83M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 11.82M shares 10-Q · filed 2025-11-03 | 11.43M shares derived: average of 2 quarters · filed 2026-08-06 | 10.73M shares 10-Q · filed 2025-11-03 | 10.04M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 11.05M shares 10-Q · filed 2026-08-06 | 10.17M shares 10-Q · filed 2026-08-06 | 9.45M shares derived: average of 3 quarters · filed 2026-08-06 | 8.91M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 9.29M shares 10-Q · filed 2026-05-05 | 8.65M shares derived: average of 2 quarters · filed 2026-05-05 | 8.20M shares derived: average of 3 quarters · filed 2026-05-05 | 7.89M shares derived: average of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | 8.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 7.65M shares derived: average of 2 quarters · filed 2026-03-12 | 7.42M shares derived: average of 3 quarters · filed 2026-03-12 | 6.83M shares 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | 7.29M shares 10-Q · filed 2025-11-03 | 7.13M shares derived: average of 2 quarters · filed 2025-11-03 | 6.44M shares 10-Q · filed 2025-11-03 | 5.83M shares derived: average of 4 quarters · filed 2025-11-03 | ||||
| 2024-06-30 | 6.97M shares 10-Q · filed 2025-08-07 | 6.01M shares 10-Q · filed 2025-08-07 | 5.35M shares derived: average of 3 quarters · filed 2025-08-07 | 4.97M shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 5.06M shares 10-Q · filed 2025-05-15 | 4.54M shares derived: average of 2 quarters · filed 2025-05-15 | 4.30M shares derived: average of 3 quarters · filed 2025-05-15 | 4.18M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 4.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 3.93M shares derived: average of 2 quarters · filed 2025-03-26 | 3.88M shares derived: average of 3 quarters · filed 2025-03-26 | 3.84M shares 10-K · filed 2025-03-26 | ||||
| 2023-09-30 | 3.84M shares 10-Q · filed 2024-11-04 | 115.17M shares 10-Q · filed 2023-11-07 | 3.82M shares derived: average of 2 quarters · filed 2024-11-04 | 3.78M shares 10-Q · filed 2024-11-04 | 113.54M shares 10-Q · filed 2023-11-07 | -54.33M shares derived: average of 4 quarters · filed 2024-11-04 | ||
| 2023-06-30 | 3.80M shares 10-Q · filed 2024-08-01 | 114.10M shares 10-Q · filed 2023-08-04 | 3.76M shares 10-Q · filed 2024-08-01 | 112.71M shares 10-Q · filed 2023-08-04 | -73.72M shares derived: average of 3 quarters · filed 2024-08-01 | -27.58M shares derived: average of 4 quarters · filed 2024-08-01 | ||
| 2023-03-31 | 3.71M shares 10-Q · filed 2024-05-13 | 111.30M shares 10-Q · filed 2023-05-09 | -112.48M shares derived: average of 2 quarters · filed 2024-05-13 | -38.03M shares derived: average of 3 quarters · filed 2024-05-13 | -11.54M shares derived: average of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | -228.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -58.91M shares derived: average of 2 quarters · filed 2024-03-27 | -16.62M shares derived: average of 3 quarters · filed 2024-03-27 | 2.93M shares 10-K · filed 2024-03-27 | 87.90M shares 10-K · filed 2023-03-09 | |||
| 2022-09-30 | 110.85M shares 10-Q · filed 2023-11-07 | 89.40M shares derived: average of 2 quarters · filed 2023-11-07 | 80.13M shares 10-Q · filed 2023-11-07 | 75.13M shares derived: average of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | 67.95M shares 10-Q · filed 2023-08-04 | 64.51M shares 10-Q · filed 2023-08-04 | 63.23M shares derived: average of 3 quarters · filed 2023-08-04 | 62.34M shares derived: average of 4 quarters · filed 2023-08-04 | ||||
| 2022-03-31 | 61.03M shares 10-Q · filed 2023-05-09 | 60.86M shares derived: average of 2 quarters · filed 2023-05-09 | 60.46M shares derived: average of 3 quarters · filed 2023-05-09 | 59.78M shares derived: average of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | 60.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 60.18M shares derived: average of 2 quarters · filed 2023-03-09 | 59.36M shares derived: average of 3 quarters · filed 2023-03-09 | 58.69M shares 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | 59.66M shares 10-Q · filed 2022-11-08 | 58.70M shares derived: average of 2 quarters · filed 2022-11-08 | 58.02M shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 57.74M shares 10-Q · filed 2022-08-08 | 57.19M shares 10-Q · filed 2022-08-08 | ||||||
| 2020-06-30 | 51.91M shares 10-Q · filed 2021-08-12 | 51.61M shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |